Anavex Life Sciences
AVXL
#5913
Rank
A$1.18 B
Marketcap
$14.02
Share price
21.02%
Change (1 day)
55.31%
Change (1 year)

Anavex Life Sciences (AVXL) - Cash on Hand

Cash on Hand as of June 2024 : A$0.21 Billion

According to Anavex Life Sciences 's latest financial reports the company has A$0.21 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Anavex Life Sciences - Cash on Hand chart (from 2005 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-09-30A$0.23 B2.59%
2022-09-30A$0.22 B8.1%
2021-09-30A$0.21 B417.41%
2020-09-30A$40.94 M24.77%
2019-09-30A$32.81 M3.38%
2018-09-30A$31.74 M-9.33%
2017-09-30A$35 M190.67%
2016-09-30A$12.04 M-44.84%
2015-09-30A$21.83 M162.06%
2014-09-30A$8.33 M2145.65%
2013-09-30A$0.37 M3288.59%
2012-09-30A$0.01 M-92.06%
2011-09-30A$0.13 M-49.48%
2010-09-30A$0.27 M-31.25%
2009-09-30A$0.39 M4851.6%
2008-09-30A$0 M28082.87%
2007-09-30A$0 M-99.83%
2006-09-30A$0.01 M1179.05%
2005-09-30A$0 M-96.72%
2004-09-30A$0.03 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$0.34 B 63.55%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.41 B 96.05%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.57 B 174.10%๐Ÿ‡บ๐Ÿ‡ธ USA
A$14.45 M-93.13%๐Ÿ‡บ๐Ÿ‡ธ USA